AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Pubs Acs

Published November 5, 2026 · Updated November 6, 2026

Next-Generation Psychedelic Drug Development | ACS Chemical Neuroscience

Read the full story at Pubs Acs

Keywords psychedelics , psilocybin, nonpsychedelic analogs, 5-HT2A, Biotech , drug development. Introduction. Psychedelic compounds have taken center.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelic biotech